ERYP

Erytech Pharma (ERYP)

Erytech Pharma SA

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ERYP

1 2 3 4 5 6 7 8 9 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/07/01	00 : 33	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ERYP	Erytech Pharma SA
2023/06/30	04 : 53	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:ERYP	Erytech Pharma SA
2023/06/30	04 : 52	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ERYP	Erytech Pharma SA
2023/06/28	21 : 54	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ERYP	Erytech Pharma SA
2023/06/28	21 : 53	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:ERYP	Erytech Pharma SA
2023/06/21	19 : 10	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ERYP	Erytech Pharma SA
2023/06/12	23 : 34	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ERYP	Erytech Pharma SA
2023/05/25	05 : 52	Edgar (US Regulatory)	Appointment of Agent for Service of Process and Undertaking (f-x)	NASDAQ:ERYP	Erytech Pharma SA
2023/05/24	21 : 26	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ERYP	Erytech Pharma SA
2023/05/16	23 : 14	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ERYP	Erytech Pharma SA
2023/05/09	23 : 30	AllPennyStocks.com	Micro Cap Bid Up Right Before Opening Bell	NASDAQ:ERYP	Erytech Pharma SA
2023/04/18	21 : 21	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ERYP	Erytech Pharma SA
2023/03/23	22 : 38	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ERYP	Erytech Pharma SA
2023/02/15	02 : 51	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ERYP	Erytech Pharma SA
2023/02/14	20 : 13	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ERYP	Erytech Pharma SA
2022/12/24	07 : 09	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ERYP	Erytech Pharma SA
2022/11/23	01 : 10	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ERYP	Erytech Pharma SA
2022/10/14	19 : 12	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ERYP	Erytech Pharma SA
2022/08/26	02 : 21	Dow Jones News	Erytech Pharma Shares Hit 52-Week Low After Ending Plans for License Application for Graspa	NASDAQ:ERYP	Erytech Pharma SA
2022/08/25	23 : 14	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ERYP	Erytech Pharma SA
2022/06/28	22 : 02	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ERYP	Erytech Pharma SA
2022/05/14	00 : 37	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ERYP	Erytech Pharma SA
2022/05/02	22 : 48	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ERYP	Erytech Pharma SA
2022/04/28	21 : 32	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ERYP	Erytech Pharma SA
2022/04/28	01 : 51	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:ERYP	Erytech Pharma SA
2022/04/26	05 : 32	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ERYP	Erytech Pharma SA
2022/03/15	22 : 20	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ERYP	Erytech Pharma SA
2022/02/15	20 : 30	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ERYP	Erytech Pharma SA
2022/02/15	03 : 49	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ERYP	Erytech Pharma SA
2022/02/10	22 : 26	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:ERYP	Erytech Pharma SA